Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M710415200 on June 20, 2008

J. Biol. Chem., Vol. 283, Issue 33, 22417-22429, August 15, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/33/22417    most recent
M710415200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kota, S.
Right arrow Articles by Bose, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kota, S.
Right arrow Articles by Bose, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of Human β-Defensin-2 during Tumor Necrosis Factor-{alpha}/NF-{kappa}B-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus*Formula

Srikanth Kota, Ahmed Sabbah, Te Hung Chang, Rosalinda Harnack, Yan Xiang, Xiangzhi Meng, and Santanu Bose1

From the Department of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229

Human respiratory syncytial virus (RSV) constitutes a highly pathogenic virus that infects lung epithelial cells to cause a wide spectrum of respiratory diseases. Our recent studies have revealed the existence of an interferon-{alpha}/β-independent, innate antiviral response against RSV that was dependent on activation of NF-{kappa}B. We demonstrated that NF-{kappa}B inducing pro-inflammatory cytokines like tumor necrosis factor-{alpha} (TNF) confers potent antiviral function against RSV in an NF-{kappa}B-dependent fashion, independent of interferon-{alpha}/β. During our efforts to study this pathway, we identified HBD2 (human β-defensin-2), a soluble secreted cationic protein as an antiviral factor induced during NF-{kappa}B-dependent innate antiviral activity in human lung epithelial cells. Our results demonstrated that HBD2 is induced by TNF and RSV in an NF-{kappa}B-dependent manner. Induction of HBD2 in infected cells was mediated by the paracrine/autocrine action of TNF produced upon RSV infection. HBD2 plays a critical role during host defense, because purified HBD2 drastically inhibited RSV infection. We also show that the antiviral mechanism of HBD2 involves blocking of viral cellular entry possibly because of destabilization/disintegration of the viral envelope. The important role of HBD2 in the innate response was also evident from loss of antiviral activity of TNF upon HBD2 silencing by short interfering RNA. The in vivo physiological relevance of HBD2 in host defense was apparent from induction of murine β-defensin-4 (murine counterpart of HBD2) in lung tissues of RSV-infected mice. Thus, HBD2 functions as an antiviral molecule during NF-{kappa}B-dependent innate antiviral immunity mediated by the autocrine/paracrine action of TNF.


Received for publication, December 21, 2007 , and in revised form, June 10, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants AI069062 and CA129246 (to S. B.) and T32-DE14318 (to S. B. and A. S.). This work was also supported by American Lung Association National Biomedical Research Grant RG-49629-N (to S. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S6.

1 To whom correspondence should be addressed: Dept. of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, 7703 Floyd Curl Dr., MC-7758, San Antonio, TX 78229. Fax: 210-567-6612; E-mail: bose{at}uthscsa.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. S. Dugan, M. S. Maginnis, J. A. Jordan, M. L. Gasparovic, K. Manley, R. Page, G. Williams, E. Porter, B. A. O'Hara, and W. J. Atwood
Human {alpha}-Defensins Inhibit BK Virus Infection by Aggregating Virions and Blocking Binding to Host Cells
J. Biol. Chem., November 7, 2008; 283(45): 31125 - 31132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement